{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:21:57Z","timestamp":1747200117741,"version":"3.40.5"},"reference-count":47,"publisher":"Media Sphere Publishing House","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2022]]},"DOI":"10.17116\/jnevro202212207136","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:21:36Z","timestamp":1659097296000},"page":"36","source":"Crossref","is-referenced-by-count":2,"title":["Possibilities of individual choice of NSAIDs on the example of the oxicam class, taking into account clinical and pharmacological characteristics"],"prefix":"10.17116","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-8501","authenticated-orcid":false,"given":"M.V.","family":"Putilina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-4680","authenticated-orcid":false,"given":"N.V.","family":"Teplova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202212207136-1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001390"},{"key":"key-10.17116\/jnevro202212207136-2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37371"},{"key":"key-10.17116\/jnevro202212207136-3","unstructured":"Putilina MV, Naumov AV, Teplova NV. Chronic pain syndromes. Medical Alphabet. 2021;8(3):12-17. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-4","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2018-1-29"},{"key":"key-10.17116\/jnevro202212207136-5","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-018-2316-z"},{"key":"key-10.17116\/jnevro202212207136-6","doi-asserted-by":"crossref","unstructured":"Putilina MV. Patient comorbidity in clinical practice. Consilium Medicum. 2017;19(2):71-79. (In Russ.)","DOI":"10.26442\/2075-1753_19.2.71-79"},{"key":"key-10.17116\/jnevro202212207136-7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00659"},{"key":"key-10.17116\/jnevro202212207136-8","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2015.1088840"},{"key":"key-10.17116\/jnevro202212207136-9","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1334"},{"key":"key-10.17116\/jnevro202212207136-10","unstructured":"Yakhno NN, Kukushkin ML, Churyukanov MV, et al. The results of open multicentral study \u00abMeridian\u00bb for assessment of pain syndromes prevalence in ambulatory and therapeutic preferences of physicians. Russian Journal of Pain. 2012;3-4:10-14. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-11","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.5b01378"},{"key":"key-10.17116\/jnevro202212207136-12","unstructured":"Andryukov KV, Korkodinova LM. Search for compounds with analgesic activity using molecular docking in \u00abstructure-activity\u00bb studies on COX1 and 2 enzymes in the series of substituted anthranilic acids International. Journal of Applied and Basic Research. 2019;12-1:60-64. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.11.046"},{"key":"key-10.17116\/jnevro202212207136-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2012.05.045"},{"key":"key-10.17116\/jnevro202212207136-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.08.078"},{"key":"key-10.17116\/jnevro202212207136-16","unstructured":"Karateev AE. Meloxicam: The golden mean of nonsteroidal anti-inflammatory drugs. Terapevticheskii Arkhiv. 2014;86(5):99-105. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-17","unstructured":"Instructions for the medical use of the drug Artrozan tablets RU LS-001013 dated 05\/31\/2010. Artrozan solution for intramuscular injection RU LP \u2014 No. 000537 dated 02.01.2022. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-18","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199803090-00016"},{"key":"key-10.17116\/jnevro202212207136-19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.151415"},{"key":"key-10.17116\/jnevro202212207136-20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3185"},{"key":"key-10.17116\/jnevro202212207136-21","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2019-1-46-50"},{"key":"key-10.17116\/jnevro202212207136-22","doi-asserted-by":"crossref","unstructured":"Hawkey C, Kahan A, Steinbruck K, et al. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large Scale International Study Safety Assessment. Br J Rheumatol. 1988;37:937-945","DOI":"10.1093\/rheumatology\/37.9.937"},{"key":"key-10.17116\/jnevro202212207136-23","doi-asserted-by":"crossref","unstructured":"Dequeker J, Hawkey C, Kahan A, et al. Improvement in gastrointestinal tolerability on the selective cyclooxygenase (COX)-2 inhibitor meloxicam, compared with piroxicam: results of the Safety and Efficacy Large scale Evalution of COX inhibiting Therapies (SELECT) trial in osteoarthritis. Br J Rheumatol. 1998;37:946-951","DOI":"10.1093\/rheumatology\/37.9.946"},{"key":"key-10.17116\/jnevro202212207136-24","doi-asserted-by":"crossref","unstructured":"Lapeyre-Mestre M, Grolleau S, Montastruc JL. Association Fran\u00e7aise des Centres R\u00e9gionaux de Pharmacovigilance (CRPV) Adverse drug reactions associated with the use of NSAIDs: a case\/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002\u20142006. Fundam Clin Pharmacol. 2013;27(2):223-230","DOI":"10.1111\/j.1472-8206.2011.00991.x"},{"key":"key-10.17116\/jnevro202212207136-25","doi-asserted-by":"crossref","unstructured":"Singh G, Lanes S, Triadafilopoulos G. Risk upper gastrointestinal\/cardiovascular thromboembolic complications with meloxicam. Am J Med. 2004;117(2):100-106","DOI":"10.1016\/j.amjmed.2004.03.012"},{"key":"key-10.17116\/jnevro202212207136-26","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-014-0225-9"},{"key":"key-10.17116\/jnevro202212207136-27","doi-asserted-by":"publisher","DOI":"10.14412\/1996-7012-2019-2-31-37"},{"key":"key-10.17116\/jnevro202212207136-28","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2020120081117"},{"key":"key-10.17116\/jnevro202212207136-29","doi-asserted-by":"publisher","DOI":"10.17116\/pain20222001142"},{"key":"key-10.17116\/jnevro202212207136-30","unstructured":"Barsukova NA, Pyshnograeva LV. Experience in the clinical use of the drug Artrozan in patients with osteoarthritis and concomitant erosive and ulcerative lesions of the gastrointestinal tract. Pharmateka. 2007;12:1-3. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-31","unstructured":"Zaripova AI, Khuzina GR, Sakovets TG. Cervicogenic headache: differential diagnostic and pharmacotherapeutic aspects. Modern Medicine. Neurology. Rehabilitation. 2020;1(17):71-78. (In Russ.)"},{"key":"key-10.17116\/jnevro202212207136-32","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.772"},{"key":"key-10.17116\/jnevro202212207136-33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.4.458"},{"key":"key-10.17116\/jnevro202212207136-34","doi-asserted-by":"publisher","DOI":"10.1177\/009127002401102795"},{"key":"key-10.17116\/jnevro202212207136-35","doi-asserted-by":"crossref","unstructured":"Putilina MV, Shabalina NI, Grishin DV, et al. Meloxicame effect on coagulogram parameters in patients with back pain after suffering a coronovirus infection COVID-19. Rmj. 2022;4:11-14. (In Russ.)","DOI":"10.17116\/pain20222001142"},{"key":"key-10.17116\/jnevro202212207136-36","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1996.tb04155.x"},{"key":"key-10.17116\/jnevro202212207136-37","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0214"},{"key":"key-10.17116\/jnevro202212207136-38","doi-asserted-by":"crossref","unstructured":"Altman R, Luciardi H, Muntaner J, et al. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study. Circulation. 2002;106(2):191-195","DOI":"10.1161\/01.CIR.0000021599.56755.A1"},{"key":"key-10.17116\/jnevro202212207136-39","doi-asserted-by":"crossref","unstructured":"Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet. 1994;26(1):16-43","DOI":"10.2165\/00003088-199426010-00003"},{"key":"key-10.17116\/jnevro202212207136-40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051027"},{"key":"key-10.17116\/jnevro202212207136-41","doi-asserted-by":"crossref","unstructured":"Karateev AE. Non-steroidal anti-inflammatory drugs use in clinical practice: new opportunities. Consilium Medicum. 2018;2(9):88-94. (In Russ.)","DOI":"10.26442\/2075-1753_2018.9.88-94"},{"key":"key-10.17116\/jnevro202212207136-42","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-015-2990-5"},{"key":"key-10.17116\/jnevro202212207136-43","doi-asserted-by":"crossref","unstructured":"Ahmed MO, Al-Badr AA. Lornoxicam, Comprehensive Profile, Profiles of Drug Substances, Excipients and Related Methodology. Profiles of Drug Substances, Excipients and Related Methodology. 2011;36:205-237","DOI":"10.1016\/B978-0-12-387667-6.00006-3"},{"key":"key-10.17116\/jnevro202212207136-44","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.16.7"},{"key":"key-10.17116\/jnevro202212207136-45","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2019.01.000039"},{"key":"key-10.17116\/jnevro202212207136-46","doi-asserted-by":"crossref","unstructured":"Radhofer-Welte S, Dittrich P, Simin M, et al. Comparative bioavailability of lornoxicam as single doses of quick-release tablet, standard tablet and intramuscular injection: a randomized, open-label, crossover phase I study in healthy volunteers. Clin Drug Investig. 2008;28:345-351","DOI":"10.2165\/00044011-200828060-00002"},{"key":"key-10.17116\/jnevro202212207136-47","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202012001170"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T12:32:59Z","timestamp":1659097979000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2022\/7\/1199772982022071036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"alternative-id":["10.17116\/jnevro202212207136"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202212207136","relation":{},"ISSN":["1997-7298"],"issn-type":[{"type":"print","value":"1997-7298"}],"subject":[],"published":{"date-parts":[[2022]]}}}